STING1 and head and neck cancer: For instance, David et al. developed a novel injectable peptide hydrogel termed STINGel for the controlled release of STING agonists, which activates the STING pathway, bolsters innate immunity, and significantly improves the survival rate in mice with head and neck cancer [222].